When it comes to medical research and advancement, we usually hear about the results of a successful study or a new drug in the latter stages of a clinical trial. Rarely does the media report on trials gone wrong or the unethical aspects of medical research. This is starting to change. A May 16 New York Times article, "Drug Trials Hide Conflicts for Doctors," presented a scathing view of the patient recruitment process, the result of a 10-month investigation. The report highlights the disturbing trend of pharmaceutical companies that offer doctors financial incentives to recruit patients in a timely fashion.
Clinical Trial Methods Attracting Closer Media Scrutiny of Patient Recruitment
You might also be interested in:
- 6 Steps to Help Coordinate a Crisis Response in a Large Corporation
- The Week in PR
- How to Use Social and Traditional Media to Promote Your White Paper
- A Job for Communicators: Just 47% of Workers Receive Diversity Training
- Tips and Tricks to Use Facebook's New Live Video Feature to Boost Brand Engagement